Skip to Content

Money

Pills lying in a packaging machine at pharmaceuticals manufacturer AstraZeneca in Germany in October 2016.

Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goals

By Tami Luhby, CNN (CNN) — Ever since President Donald Trump started promising to slap tariffs on pharmaceutical imports, drugmakers have unveiled a flurry of commitments to build or expand US manufacturing operations in the coming years. AstraZeneca is investing $50 billion to expand its drug manufacturing in the US. Johnson & Johnson is pouring

Continue Reading
People walk by the Apple Store on Fifth Avenue during sunset in New York City. Apple reported strong iPhone sales and rebound in revenue from China.

Apple got a much-needed iPhone and China boost, but expects a $1.1 billion tariff hit this quarter

By Lisa Eadicicco, CNN (CNN) — Apple reported strong iPhone sales and rebound in revenue from China, giving a much-needed boost to two parts of the company’s business that had struggled over the past year. That better-than-expected performance reassured Wall Street investors that key parts of its business are holding steady as Apple struggles to

Continue Reading